Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Iradimed is a leading US medical technology company that develops and manufactures innovative, MRI-compatible medical devices. Specializing in MR-safe infusion systems, Iradimed enhances patient safety within MRI environments. The company provides reliable medical technology for precise applications.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Iradimed is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Iradimed last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 0.46 USD.
Across its last 4 earnings reports, Iradimed stock moved by ±8% on average the following day. The largest reaction was +9.6% on 02/10/2026; 3 of 4 reactions were positive.
Iradimed has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.